The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world

Epidemiology and Infection

Volumn 124, Issue 3, 2000, Pages 449-457

  Kelly, H A ^a   Siebert, D ^b   Hammond, R ^a   Leydon, J ^a   Kiely, P ^c   Maskill, W ^a  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; BLOOD STORAGE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARVOVIRUS; PREVALENCE; PROSPECTIVE STUDY; PUBLIC HEALTH; PUBLICATION; RED CROSS; SEROEPIDEMIOLOGY; VIRUS IMMUNITY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODY FORMATION; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CLIMATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREVALENCE; SEASONS;

EID: 0033870016     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899003817     Document Type: Article

References (44)

1. Human parvovirus, the cause of erythema infectiosum (fifth disease)?
2. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro
3. Diverse haematological effects of parvovirus B19 infection
4. Parvovirus B19-associated haemophagocytic syndrome in healthy adults
5. The role of parvovirus in aplastic crisis and erythema infectiosum (fifth disease)
6. Parvovirus B19: An expanding spectrum of disease
7. Immediate and long term outcome of human parvovirus B19 infection in pregnancy
8. Parvovirus B19 and human disease
9. Risk factors for parvovirus B19 infection in pregnancy
10. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods
11. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum
12. Occupational risk factors for infection with parvovirus B19 among pregnant women
13. Parvovirus as a cause for anaemia in human immunodeficiency virus-infected patients
14. Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for pre-existing anti-B19 antibody: How reliable are serological results?
15. Age specific antibody prevalence to parvovirus B19; how many women are infected in pregnancy?
16. The prevalence of antibody to human parvovirus B19 in England and Wales
17. Fifth diseases in a small rural community - What are the consequences
18. Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: Differential implications for prevention of transfusional transmission
19. Human parvovirus infections in France 1984-86
20. Seroepidemiology of human parvovirus B19 in Taiwan
21. Parvovirus B19 infection in Hong Kong
22. Low prevalence of antibody to human parvovirus B19 in Singapore
23. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa
24. Sero-prevalence of varicella-zoster virus antibody in Thailand
25. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade
26. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil
27. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil
28. Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia
29. Seroprevalence of IgG antibodies against parvovirus B19 in the population of the Czech Republic
30. Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals
31. Incidence of parvovirus B19 infection. Seroepidemiologic studies
32. Parvovirus B19 infections in Germany 1987-1988
33. Parvovirus B19 infection in pregnancy
34. Human parvovirus B19: Immunity of Greek females and prenatal investigation of hydrops fetalis
35. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients
36. Human parvovirus B19 infection in blood donors
37. Seroepidemiology of human parvovirus B19 using recombinanat VP1 + VP2 particle antigen
38. Seroprevalence of human parvovirus B19 in children of a desert region
39. Seroprevalence of human parvovirus B19 infection in Sao Tome and Principe, Malawi and Mascarene Islands
40. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
41. Prevalence of parvovirus B19 infection in Portugal
42. IgG and IgM antibodies to human parvovirus B19 in the serum of patients with a clinical diagnosis of infection with the virus and in the general population of Saudi Arabia
43. Seroprevalence versus parvovirus B19 in blood donors
44. A prospective study of antibodies against parvovirus B19 in pregnancy